Repeated measurements of alkaline phosphatase in a randomized trial of Tamoxifen treatment of breast cancer patients.
alkfosA data frame with 43 observations on the following 8 variables.
grpa numeric vector, group code (1=placebo, 2=Tamoxifen).
c0a numeric vector, concentration at baseline.
c3a numeric vector, concentration after 3 months.
c6a numeric vector, concentration after 6 months.
c9a numeric vector, concentration after 9 months.
c12a numeric vector, concentration after 12 months.
c18a numeric vector, concentration after 18 months.
c24a numeric vector, concentration after 24 months.
B. Kristensen et al. (1994), Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. Journal of Clinical Oncology, 12(2):992--997.